Latest Announcements

IIFL Finance Limited has announced a primary private equity infusion of ₹6,414 Crores ($686 million) led by Blackstone and the promoters, with Blackstone investing ₹5,000 crores ($535 million) and the promoters investing ₹1,264 crores ($135 million).

TVS Srichakra Limited has released a Diwali film titled 'Worth the Wait' that explores a centuries-old Diwali custom in the village of Chilla, near Chandigarh. The film is available on YouTube and Eurogrip's social media channels.

Oval Projects Engineering Ltd has disclosed its earnings call transcript under Regulation 30A of LODR, providing insights into its financial performance and future prospects.

Adani Power Ltd has informed the Exchange about Credit Rating upgrade to [ICRA] AA+ (Stable) from [ICRA] AA (Stable) by ICRA Limited.

ARSS Infrastructure Projects Limited has submitted its financial results for the quarter and half year ended September 30, 2026. The company has increased its authorized share capital from ₹500 Crore to ₹1,100 Crore, comprising of ₹230 Crore divided into 23 Crore Equity Shares of ₹10/- each and ₹870 Crore divided into 87 Crore Preference Shares of ₹10/- each. The company has also announced material related party transactions with Ocean Capital Market Limited and Mr. Dipti Ranjan Patnaik, promoters, and plans to issue non-convertible redeemable preference shares to them on private placement basis. The company has also arranged for remote e-voting for the shareholders to approve the resolutions.

IIFL Finance Ltd has announced a primary capital raise of ₹6,414 crores ($686 million) through a preferential issue, with Blackstone Private Equity investing ₹5,000 crores ($535 million) and the promoters investing ₹1,264 crores ($135 million). The funds will strengthen the company's capital adequacy, improve its cost of funds, and accelerate growth in its gold finance business.

Aptus Value Housing Finance India Ltd has published a newspaper advertisement for the dispatch of the Postal Ballot Notice for the approval of the ESOP scheme 2026, as per Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.

Alembic Pharmaceuticals Ltd's Q2 and H1 FY27 earnings conference call highlights strong performances across all businesses, with consolidated revenue growing 36% Y-on-Y. The India business delivered a 14% year-on-year growth, led by Human Health, while the U.S. Generics business saw exceptional growth with revenue increasing 72% Y-on-Y. The company also announced an expanded strategic collaboration with DifGen Pharmaceuticals.

Matrimony.com Ltd announced its unaudited standalone and consolidated financial results for the second quarter ended September 30, 2026, with a 167% y/y growth in PAT, and revenue growth of 17.6% y/y and 3.3% q/q.

S.J.S. Enterprises Ltd has informed the Exchange about attending a 17th Annual Investor Conference, India Xchange 2026 organized by JM Financial, on 17th Nov 2026 in Mumbai from 12:00 PM (IST) onwards.

Alembic Pharmaceuticals Limited held an earnings conference call for Q2 and H1 FY27, with a consolidated revenue growth of 36% Y-on-Y. The company's India business delivered a 14% year-on-year growth, driven by strong performances in Human Health and Animal Health. The U.S. Generics business showed exceptional growth with revenue increasing by 72% year-on-year. The company also announced an expansion of its strategic collaboration with DifGen Pharmaceuticals, giving access to a differentiated portfolio of over 20 products.

Ind-Swift Laboratories Ltd has announced its Q2 FY27 earnings, with a 50.15% year-on-year increase in operating revenue to ₹234.89 crore. The company's operating EBITDA rose 4.95x year-on-year to ₹42.33 crore, and the operating EBITDA margin expanded 1,256 basis points to 18.02%. The PAT surged 3.54x year-on-year to ₹31.03 crore, delivering a PAT margin of 13.21%. The company's H1 FY27 performance also saw a 35.79% year-on-year increase in operating revenue to ₹420.97 crore, with operating EBITDA surging 4.45 times to ₹75.65 crore and EBITDA margin expanding by 1,254 basis points to 17.97%. The company's export footprint remains the primary growth engine, with 82.7% of total sales, while domestic verticals continue to provide steady cash flow stability with 17.3% of total sales.

Ind-Swift Laboratories Limited has informed the Exchange about the transcript of the Conference Call held on Wednesday, November 04, 2026, with Analysts/Investors to discuss the Un-audited Financial Results of the Company for the quarter ended September 30, 2026 (Q2 FY27).

Covance Softsol Ltd approved unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, as recommended by the Audit Committee.

Inventurus Knowledge Solutions Ltd has acquired 100% of Turbo Health Holdings, LLC for USD 500,000. The acquisition is in the healthcare technology and IT services/software industry. The acquisition is expected to strengthen the company's solutions and deliver greater value to its clients.

S.J.S. Enterprises Limited has informed the Exchange about attending a 17th Annual Investor Conference, India Xchange 2026 organized by JM Financial, on 17th Nov 2026 in Mumbai from 12:00 PM (IST) onwards.

Inventurus Knowledge Solutions Limited has informed the Exchange about Acquisition of Turbo Health Holdings, LLC. The acquisition represents an important opportunity to expand organisation's market reach. The complementary capabilities, expertise, and relationships will strengthen organisation's solutions and deliver greater value to healthcare organizations and clients it serves.

Vision Cinemas Ltd has announced its unaudited financial results for the quarter and half year ended September 30, 2026. The company's standalone and consolidated financial results have been approved by the Board of Directors. The results are accompanied by a limited review report from the statutory auditors. The review report notes that nothing has come to their attention that causes them to believe that the financial results have not disclosed the information required to be disclosed under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. However, the report draws attention to a non-compliance regarding the disclosure of the impact of pending litigations on the company's financial position.

Redington Limited has announced its Q2 FY 2026-27 earnings conference call transcript, with consolidated revenue reaching INR43,002 crores, a 48% year-on-year growth, and profit after tax excluding exceptional items rising 50% to INR581 crores.

Global Health Ltd has announced a schedule for an institutional investor meet, to be held on November 19 and 20, 2026, with various asset management firms and investment companies. The meeting will be held in person and will not involve the sharing of unpublished price sensitive information.